Hepatitis C

Hepatitis C News

  • Alert CHMP Backs Two Pan-Genotypic Antivirals for Hep C Maviret and Vosevi were evaluated under the European Union's accelerated assessment, which speeds access to new medicines where there is an unmet medical need.
  • Elbasvir-Grazoprevir Effective Against HCV in CKD The fixed-dose combination of elbasvir and grazoprevir is safe and effective for treating chronic hepatitis C virus (HCV) infection in patients with stage 4-5 chronic kidney disease (CKD), according to results from the C-SURFER study.

Hepatitis C Perspective

  • Hepatitis C Virus: Containing the Threat   HCV treatments are highly efficacious, but challenges remain in screening persons at risk of contracting and spreading infection, as well as in the treatment of liver diseases caused by HCV.
  • 10 Key Primary Care Takeaways: DDW 2017   The 'really hot stuff' from this year's Digestive Disease Week that will interest primary care providers, according to Dr David Johnson.